{"id":"daytime-dosing-of-mirabegron","safety":{"commonSideEffects":[{"rate":"1-3%","effect":"Hypertension"},{"rate":"2-4%","effect":"Headache"},{"rate":"1-2%","effect":"Tachycardia"},{"rate":"2-3%","effect":"Nasopharyngitis"},{"rate":"1-2%","effect":"Urinary tract infection"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Mirabegron activates beta-3 adrenergic receptors on the smooth muscle of the bladder detrusor, causing relaxation and increased bladder capacity during the storage phase of the micturition cycle. Unlike anticholinergic agents, it does not block muscarinic receptors, resulting in a different side effect profile. This mechanism allows increased urine storage without affecting bladder emptying.","oneSentence":"Mirabegron is a beta-3 adrenergic receptor agonist that relaxes the detrusor muscle in the bladder to increase urine storage capacity.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:44:07.725Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Overactive bladder with symptoms of urge incontinence, urgency, and urinary frequency"}]},"trialDetails":[{"nctId":"NCT03251300","phase":"PHASE4","title":"Mirabegron for Female OAB Patients: Comparison of Daytime and Nighttime Dosing","status":"UNKNOWN","sponsor":"Far Eastern Memorial Hospital","startDate":"2017-08-01","conditions":"Overactive Bladder Syndrome","enrollment":120}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"daytime dosing of mirabegron","genericName":"daytime dosing of mirabegron","companyName":"Far Eastern Memorial Hospital","companyId":"far-eastern-memorial-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Mirabegron is a beta-3 adrenergic receptor agonist that relaxes the detrusor muscle in the bladder to increase urine storage capacity. Used for Overactive bladder with symptoms of urge incontinence, urgency, and urinary frequency.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}